RT Journal Article
SR Electronic
T1 Correcting under-reported COVID-19 case numbers: estimating the true scale of the pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.14.20036178
DO 10.1101/2020.03.14.20036178
A1 Jagodnik, Kathleen M.
A1 Ray, Forest
A1 Giorgi, Federico M.
A1 Lachmann, Alexander
YR 2020
UL http://medrxiv.org/content/early/2020/04/05/2020.03.14.20036178.abstract
AB The COVID-19 virus has spread worldwide in a matter of a few months, while healthcare systems struggle to monitor and report current cases. Testing results have struggled with the relative capabilities, testing policies and preparedness of each affected country, making their comparison a non-trivial task. Since severe cases, which more likely lead to fatal outcomes, are detected at a higher rate than mild cases, the reported virus mortality is likely inflated in most countries. Lockdowns and changes in human behavior modulate the underlying growth rate of the virus. Under-sampling of infection cases may lead to the under-estimation of total cases, resulting in systematic mortality estimation biases. For healthcare systems worldwide it is important to know the expected number of cases that will need treatment. In this manuscript, we identify a generalizable growth rate decay reflecting behavioral change. We propose a method to correct the reported COVID-19 cases and death numbers by using a benchmark country (South Korea) with near-optimal testing coverage, with considerations on population demographics. We extrapolate expected deaths and hospitalizations with respect to observations in countries that passed the exponential growth curve. By applying our correction, we predict that the number of cases is highly under-reported in most countries and a significant burden on worldwide hospital capacity.The full analysis workflow and data is available at: https://github.com/lachmann12/covid19Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data is available on the Kaggle platform. https://www.kaggle.com/lachmann12/correcting-under-reported-covid-19-case-numbers https://github.com/lachmann12/covid19